nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Angina pectoris—Fluorouracil—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Rescinnamine—Stinging—Epirubicin—pancreatic cancer	0.00324	0.00324	CcSEcCtD
Rescinnamine—Herpes zoster—Doxorubicin—pancreatic cancer	0.00323	0.00323	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.0031	0.0031	CcSEcCtD
Rescinnamine—Gingivitis—Doxorubicin—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Rescinnamine—Myocardial infarction—Irinotecan—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Rescinnamine—Abscess—Doxorubicin—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Rescinnamine—Cough—Tamoxifen—pancreatic cancer	0.00304	0.00304	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Rescinnamine—Hypertension—Tamoxifen—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Rescinnamine—Cough—Erlotinib—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Rescinnamine—Myocardial infarction—Gemcitabine—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Rescinnamine—Stinging—Doxorubicin—pancreatic cancer	0.003	0.003	CcSEcCtD
Rescinnamine—Erythema—Sunitinib—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Rescinnamine—Myalgia—Tamoxifen—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Rescinnamine—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Rescinnamine—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Rescinnamine—Myalgia—Erlotinib—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Rescinnamine—Discomfort—Tamoxifen—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Rescinnamine—Urinary tract infection—Fluorouracil—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Rescinnamine—Conjunctivitis—Fluorouracil—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Rescinnamine—Dysgeusia—Sunitinib—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Rescinnamine—Skin discolouration—Epirubicin—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Rescinnamine—Back pain—Sunitinib—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Rescinnamine—Cough increased—Epirubicin—pancreatic cancer	0.00287	0.00287	CcSEcCtD
Rescinnamine—Lacrimation increased—Epirubicin—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Rescinnamine—Oedema—Tamoxifen—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Rescinnamine—Rhinitis—Irinotecan—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Rescinnamine—Sinusitis—Fluorouracil—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Rescinnamine—Infection—Tamoxifen—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Rescinnamine—Oedema—Erlotinib—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Rescinnamine—Infection—Erlotinib—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Rescinnamine—Rhinitis—Gemcitabine—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Rescinnamine—Pharyngitis—Gemcitabine—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Rescinnamine—Rhinitis—Fluorouracil—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Rescinnamine—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Rescinnamine—Skin discolouration—Doxorubicin—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Rescinnamine—Pharyngitis—Fluorouracil—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Rescinnamine—Cough increased—Doxorubicin—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Rescinnamine—Lacrimation increased—Doxorubicin—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Rescinnamine—Vaginal inflammation—Epirubicin—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Rescinnamine—Cough—Sunitinib—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Rescinnamine—Dermatitis contact—Epirubicin—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Rescinnamine—Hypertension—Sunitinib—pancreatic cancer	0.00258	0.00258	CcSEcCtD
Rescinnamine—Insomnia—Tamoxifen—pancreatic cancer	0.00258	0.00258	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Rescinnamine—Paraesthesia—Tamoxifen—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Rescinnamine—Insomnia—Erlotinib—pancreatic cancer	0.00255	0.00255	CcSEcCtD
Rescinnamine—Myalgia—Sunitinib—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Rescinnamine—Vaginal infection—Epirubicin—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Rescinnamine—Oedema—Sunitinib—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Rescinnamine—Pain—Tamoxifen—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Rescinnamine—Constipation—Tamoxifen—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Rescinnamine—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Rescinnamine—Infection—Sunitinib—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Rescinnamine—Pain—Erlotinib—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Rescinnamine—Constipation—Erlotinib—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Rescinnamine—Dermatitis contact—Doxorubicin—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Rescinnamine—Erythema—Gemcitabine—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Rescinnamine—Back pain—Irinotecan—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Rescinnamine—Angina pectoris—Docetaxel—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Rescinnamine—Erythema—Fluorouracil—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Rescinnamine—Back pain—Gemcitabine—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Rescinnamine—Hypertonia—Epirubicin—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Rescinnamine—Vaginal infection—Doxorubicin—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Rescinnamine—Urticaria—Tamoxifen—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Rescinnamine—Abdominal pain—Tamoxifen—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Rescinnamine—Abdominal pain—Erlotinib—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Rescinnamine—Insomnia—Sunitinib—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Rescinnamine—Paraesthesia—Sunitinib—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Rescinnamine—Cough—Irinotecan—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Rescinnamine—Myocardial infarction—Docetaxel—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Rescinnamine—Hypertonia—Doxorubicin—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Rescinnamine—Hypertension—Irinotecan—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Rescinnamine—Conjunctivitis—Docetaxel—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Rescinnamine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Rescinnamine—Cough—Gemcitabine—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Rescinnamine—Constipation—Sunitinib—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Rescinnamine—Pain—Sunitinib—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Rescinnamine—Discomfort—Irinotecan—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Rescinnamine—Hypertension—Gemcitabine—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Rescinnamine—Myalgia—Gemcitabine—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Rescinnamine—Discomfort—Gemcitabine—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Rescinnamine—Pruritus—Tamoxifen—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Rescinnamine—Oedema—Irinotecan—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Rescinnamine—Myalgia—Fluorouracil—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Rescinnamine—Infection—Irinotecan—pancreatic cancer	0.002	0.002	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Rescinnamine—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Rescinnamine—Pruritus—Erlotinib—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Rescinnamine—Discomfort—Fluorouracil—pancreatic cancer	0.00198	0.00198	CcSEcCtD
Rescinnamine—Rhinitis—Docetaxel—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Rescinnamine—Oedema—Gemcitabine—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Rescinnamine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Rescinnamine—Infection—Gemcitabine—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Rescinnamine—Pharyngitis—Docetaxel—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Rescinnamine—Abdominal pain—Sunitinib—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Rescinnamine—Oedema—Fluorouracil—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Rescinnamine—Infection—Fluorouracil—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Rescinnamine—Dizziness—Tamoxifen—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Rescinnamine—Dizziness—Erlotinib—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Rescinnamine—Insomnia—Irinotecan—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Rescinnamine—Paraesthesia—Irinotecan—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Rescinnamine—Hypersensitivity—Sunitinib—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Rescinnamine—Rash—Tamoxifen—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Rescinnamine—Dermatitis—Tamoxifen—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Rescinnamine—Headache—Tamoxifen—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Rescinnamine—Rash—Erlotinib—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Rescinnamine—Dermatitis—Erlotinib—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Rescinnamine—Insomnia—Gemcitabine—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Rescinnamine—Headache—Erlotinib—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Rescinnamine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Rescinnamine—Insomnia—Fluorouracil—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Rescinnamine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Rescinnamine—Pruritus—Sunitinib—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Rescinnamine—Pain—Irinotecan—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Rescinnamine—Constipation—Irinotecan—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Rescinnamine—Erythema—Docetaxel—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Rescinnamine—Nausea—Tamoxifen—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Rescinnamine—Gastritis—Epirubicin—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Rescinnamine—Constipation—Gemcitabine—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Rescinnamine—Pain—Gemcitabine—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Rescinnamine—Nausea—Erlotinib—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Rescinnamine—Dysgeusia—Docetaxel—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Rescinnamine—Influenza—Epirubicin—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Rescinnamine—Back pain—Docetaxel—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Rescinnamine—Pain—Fluorouracil—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Rescinnamine—Dizziness—Sunitinib—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Rescinnamine—Angina pectoris—Epirubicin—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Rescinnamine—Abdominal pain—Irinotecan—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Rescinnamine—Bronchitis—Epirubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Rescinnamine—Rash—Sunitinib—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Rescinnamine—Dermatitis—Sunitinib—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Rescinnamine—Urticaria—Fluorouracil—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Rescinnamine—Headache—Sunitinib—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Rescinnamine—Cough—Docetaxel—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Rescinnamine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Rescinnamine—Hypertension—Docetaxel—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Rescinnamine—Myalgia—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Rescinnamine—Nausea—Sunitinib—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Rescinnamine—Urinary tract infection—Epirubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Rescinnamine—Conjunctivitis—Epirubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Rescinnamine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Rescinnamine—Oedema—Docetaxel—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Rescinnamine—Pruritus—Gemcitabine—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Rescinnamine—Infection—Docetaxel—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Rescinnamine—Sinusitis—Epirubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Rescinnamine—Pruritus—Fluorouracil—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Rescinnamine—Dizziness—Irinotecan—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Rescinnamine—Rhinitis—Epirubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Rescinnamine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Rescinnamine—Pharyngitis—Epirubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Rescinnamine—Sinusitis—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Rescinnamine—Dizziness—Fluorouracil—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Rescinnamine—Rash—Irinotecan—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Rescinnamine—Dermatitis—Irinotecan—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Rescinnamine—Headache—Irinotecan—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Rescinnamine—Insomnia—Docetaxel—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Rescinnamine—Paraesthesia—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Rescinnamine—Rash—Gemcitabine—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Rescinnamine—Dermatitis—Gemcitabine—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Rescinnamine—Headache—Gemcitabine—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Rescinnamine—Rash—Fluorouracil—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Rescinnamine—Dermatitis—Fluorouracil—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Rescinnamine—Headache—Fluorouracil—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Rescinnamine—Nausea—Irinotecan—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Rescinnamine—Pain—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Rescinnamine—Constipation—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Rescinnamine—Nausea—Gemcitabine—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Rescinnamine—Erythema—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Rescinnamine—Nausea—Fluorouracil—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Rescinnamine—Dysgeusia—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Rescinnamine—Back pain—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Rescinnamine—Abdominal pain—Docetaxel—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Rescinnamine—Hypersensitivity—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Rescinnamine—Cough—Epirubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Rescinnamine—Hypertension—Epirubicin—pancreatic cancer	0.000991	0.000991	CcSEcCtD
Rescinnamine—Pruritus—Docetaxel—pancreatic cancer	0.000982	0.000982	CcSEcCtD
Rescinnamine—Myalgia—Epirubicin—pancreatic cancer	0.000977	0.000977	CcSEcCtD
Rescinnamine—Discomfort—Epirubicin—pancreatic cancer	0.000965	0.000965	CcSEcCtD
Rescinnamine—Oedema—Epirubicin—pancreatic cancer	0.000937	0.000937	CcSEcCtD
Rescinnamine—Infection—Epirubicin—pancreatic cancer	0.000931	0.000931	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—pancreatic cancer	0.000927	0.000927	CcSEcCtD
Rescinnamine—Dizziness—Docetaxel—pancreatic cancer	0.000918	0.000918	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—pancreatic cancer	0.000917	0.000917	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—pancreatic cancer	0.000904	0.000904	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—pancreatic cancer	0.000893	0.000893	CcSEcCtD
Rescinnamine—Rash—Docetaxel—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Rescinnamine—Dermatitis—Docetaxel—pancreatic cancer	0.000875	0.000875	CcSEcCtD
Rescinnamine—Headache—Docetaxel—pancreatic cancer	0.00087	0.00087	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—pancreatic cancer	0.000867	0.000867	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—pancreatic cancer	0.000861	0.000861	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000853	0.000853	CcSEcCtD
Rescinnamine—Insomnia—Epirubicin—pancreatic cancer	0.000847	0.000847	CcSEcCtD
Rescinnamine—Paraesthesia—Epirubicin—pancreatic cancer	0.000841	0.000841	CcSEcCtD
Rescinnamine—Nausea—Docetaxel—pancreatic cancer	0.000825	0.000825	CcSEcCtD
Rescinnamine—Pain—Epirubicin—pancreatic cancer	0.000801	0.000801	CcSEcCtD
Rescinnamine—Constipation—Epirubicin—pancreatic cancer	0.000801	0.000801	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—pancreatic cancer	0.000784	0.000784	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000778	0.000778	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000766	0.000766	CcSEcCtD
Rescinnamine—Urticaria—Epirubicin—pancreatic cancer	0.000744	0.000744	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—pancreatic cancer	0.000741	0.000741	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—pancreatic cancer	0.000741	0.000741	CcSEcCtD
Rescinnamine—Abdominal pain—Epirubicin—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000709	0.000709	CcSEcCtD
Rescinnamine—Hypersensitivity—Epirubicin—pancreatic cancer	0.00069	0.00069	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—pancreatic cancer	0.000688	0.000688	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000685	0.000685	CcSEcCtD
Rescinnamine—Pruritus—Epirubicin—pancreatic cancer	0.000663	0.000663	CcSEcCtD
Rescinnamine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Rescinnamine—Dizziness—Epirubicin—pancreatic cancer	0.000619	0.000619	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—pancreatic cancer	0.000613	0.000613	CcSEcCtD
Rescinnamine—Rash—Epirubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Rescinnamine—Dermatitis—Epirubicin—pancreatic cancer	0.00059	0.00059	CcSEcCtD
Rescinnamine—Headache—Epirubicin—pancreatic cancer	0.000587	0.000587	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Rescinnamine—Nausea—Epirubicin—pancreatic cancer	0.000556	0.000556	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—pancreatic cancer	0.000546	0.000546	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—pancreatic cancer	0.000546	0.000546	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—pancreatic cancer	0.000543	0.000543	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—pancreatic cancer	0.000515	0.000515	CcSEcCtD
